Applied Therapeutics, Inc. (APLT)

Applied Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	30.42	79.4	49.9	16.66	53.89	57.47
Short-Term Investments	-	-	-	13.92	26.94	39.36
Cash & Short-Term Investments	30.42	79.4	49.9	30.58	80.82	96.83
Cash Growth	-75.11%	59.12%	63.17%	-62.16%	-16.53%	149.21%
Other Current Assets	4.09	4.25	4.49	6.73	7.57	5.76
Total Current Assets	34.51	83.65	54.39	37.31	88.39	102.59
Net Property, Plant & Equipment	2.58	2.79	0.45	0.86	1.3	1.71
Other Long-Term Assets	0.25	0.25	-	0.2	0.2	0.2
Total Assets	37.34	86.69	54.83	38.36	89.89	104.51
Accounts Payable	4.86	4.43	1.74	4.53	9.46	0.64
Accrued Expenses	10.67	16.14	15.29	14.76	16.56	20.19
Current Portion of Leases	0.45	0.41	0.43	0.48	0.44	0.41
Other Current Liabilities	1.77	6.31	53.73	13.66	-	-
Total Current Liabilities	17.75	27.3	71.18	33.42	26.46	21.24
Long-Term Leases	2.16	2.39	0.04	0.41	0.89	1.33
Other Long-Term Liabilities	-	-	0.76	0.46	-	-
Total Long-Term Liabilities	2.16	2.39	0.8	0.88	0.89	1.33
Total Liabilities	19.9	29.69	71.98	34.3	27.35	22.57
Shareholders' Equity	17.44	57.01	-17.15	4.06	62.54	81.94
Total Liabilities & Equity	37.34	86.69	54.83	38.36	89.89	104.51
Total Debt	2.6	2.8	0.47	0.89	1.33	1.74
Net Cash (Debt)	27.82	76.6	49.43	29.69	79.49	95.09
Net Cash Growth	-63.68%	54.97%	66.50%	-62.65%	-16.41%	158.29%
Net Cash Per Share	0.20	0.55	0.59	0.79	3.10	4.33
Book Value	17.44	57.01	-17.15	4.06	62.54	81.94
Book Value Per Share	0.12	0.41	-0.20	0.11	2.44	3.73
Tangible Book Value	17.44	57.01	-17.15	4.06	62.54	81.94
Tangible Book Value Per Share	0.12	0.41	-0.20	0.11	2.44	3.73

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q